Scarica l'app Stockscreener
2.06
2.83%
-0.06
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRVI Giù?
Forum
Previsione
Precedente Chiudi:
$2.12
Aprire:
$2.12
Volume 24 ore:
3.36M
Relative Volume:
1.05
Capitalizzazione di mercato:
$292.95M
Reddito:
$288.95M
Utile/perdita netta:
$-119.03M
Rapporto P/E:
-2.2876
EPS:
-0.9005
Flusso di cassa netto:
$60.67M
1 W Prestazione:
+1.23%
1M Prestazione:
+12.57%
6M Prestazione:
-63.41%
1 anno Prestazione:
-80.44%
Intervallo 1D:
$1.96
$2.345
Intervallo di 1 settimana:
$1.96
$2.345
Portata 52W:
$1.665
$11.55
Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile
Nome
Maravai Lifesciences Holdings Inc
Settore
Industria
Telefono
(858) 546-0004
Indirizzo
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Confronta MRVI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRVI
Maravai Lifesciences Holdings Inc
|
2.06 | 292.95M | 288.95M | -119.03M | 60.67M | -0.9005 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.00 | 115.57B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
574.16 | 60.30B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
542.47 | 37.56B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
266.86 | 35.18B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
224.73 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-12-19 | Iniziato | Guggenheim | Neutral |
| 2024-12-05 | Downgrade | Goldman | Neutral → Sell |
| 2024-11-14 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-08 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-08-13 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-04-10 | Iniziato | Craig Hallum | Buy |
| 2023-12-12 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-08-08 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2023-05-09 | Downgrade | Goldman | Buy → Neutral |
| 2023-01-05 | Downgrade | UBS | Buy → Neutral |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-11-03 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2020-12-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | Iniziato | BofA Securities | Buy |
| 2020-12-15 | Iniziato | Credit Suisse | Outperform |
| 2020-12-15 | Iniziato | Goldman | Buy |
| 2020-12-15 | Iniziato | Jefferies | Buy |
| 2020-12-15 | Iniziato | Robert W. Baird | Outperform |
| 2020-12-15 | Iniziato | Stifel | Buy |
| 2020-12-15 | Iniziato | William Blair | Outperform |
| 2020-12-14 | Iniziato | UBS | Buy |
Mostra tutto
Maravai Lifesciences Holdings Inc Borsa (MRVI) Ultime notizie
MRVI: Analyst Firm Lowers Price Target for Maravai LifeSciences | MRVI Stock News - GuruFocus
These Analysts Slash Their Forecasts On Maravai LifeSciences Following Q1 Results - Benzinga
Assessing Maravai LifeSciences: Insights From 5 Financial Analysts - Benzinga
Maravai LifeSciences (MRVI) Target Price Lowered by Baird | MRVI Stock News - GuruFocus
MRVI: Analyst Reduces Price Target but Maintains Buy Rating on M - GuruFocus
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q1 2025 Earnings Call Transcript - Insider Monkey
Maravai Lifesciences (MRVI) Price Target Reduced by Baird Analys - GuruFocus
Maravai LifeSciences Holdings Inc (MRVI) Q1 2025 Earnings Call Highlights: Navigating Growth ... - Yahoo Finance
Maravai LifeSciences Holdings, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:MRVI) - Seeking Alpha
Earnings call transcript: Maravai Lifesciences Q1 2025 sees revenue beat, stock up - Investing.com
Maravai LifeSciences Q1 Adjusted Loss Widens, Revenue Falls - marketscreener.com
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Maravai LifeSciences Q1 2025 Earnings: Revenue Beats Estimates a - GuruFocus
Maravai (MRVI) Offers 2025 Revenue Outlook Excluding Key Factors - GuruFocus
Maravai LifeSciences (MRVI) Exceeds Q1 Revenue Expectations | MR - GuruFocus
Maravai Lifesciences Reports First Quarter 2025 Financial Results | MRVI Stock News - GuruFocus
Maravai Lifesciences Reports First Quarter 2025 Financial Results - The Manila Times
Dimensional Fund Advisors LP Grows Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Class Action Filed Against Maravai LifeSciences Holdings, Inc. (MRVI)May 5, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
Maravai LifeSciences (MRVI) Expected to Announce Earnings on Monday - Defense World
Investigation announced for Long-Term Investors in shares - openPR.com
Envestnet Asset Management Inc. Lowers Stock Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Reach Out - ACCESS Newswire
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Shares Sold by Mariner LLC - Defense World
Quarterly Snapshot: Quick and Current Ratios for Maravai LifeSciences Holdings Inc (MRVI) - DWinneX
Wells Fargo & Company MN Buys 15,001 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
Investors who lost money on Maravai LifeSciences Holdings, Inc.(MRVI) should contact Levi & ... - Bluefield Daily Telegraph
MRVI Investors Have Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai ... - Bluefield Daily Telegraph
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holdings, Inc. of Class Action Lawsuit and Upcoming DeadlinesMRVI | FinancialContent - FinancialContent
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences - Business Wire
DEADLINE ALERT for SWKS, MRVI, APP, and RC: The Law Offices - GlobeNewswire
MRVI DEADLINE TODAY: Maravai LifeSciences (MRVI) Investors - GlobeNewswire
MRVI Investors Reminded of Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm - marketscreener.com
MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsMRVI - GuruFocus
The Gross Law Firm Notifies Maravai LifeSciences Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineMRVI - Morningstar
Maravai LifeSciences (MRVI) Reports Weak Q4, Faces Investor Class Action – Hagens Berman - GlobeNewswire
Levi & Korsinsky Reminds Maravai LifeSciences Investors of the Pending Class Action Lawsuit - Bluefield Daily Telegraph
Maravai LifeSciences Target of Unusually Large Options Trading (NASDAQ:MRVI) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences - marketscreener.com
MRVI Shares Experience Decline in Value - knoxdaily.com
The Gross Law Firm Notifies Shareholders of Maravai LifeSciences Holdings, Inc.(MRVI) of a ... - Bluefield Daily Telegraph
Holzer & Holzer, LLC Reminds Investors of the May 5, 2025 - GlobeNewswire
Balance Sheet Insights: Maravai LifeSciences Holdings Inc (MRVI)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX
Maravai LifeSciences to Announce Q1 2025 Financial Results and Host Conference Call on May 12, 2025 - Nasdaq
Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025 - GlobeNewswire
Lost Money on Maravai LifeSciences Holdings, Inc.(MRVI)? Join Class Action Suit Seeking RecoveryContact The Gross Law Firm - PR Newswire
MRVI Deadline: MRVI Investors with Losses in Excess of $100K Have Opportunity to Lead Maravai Lifesciences Holdings, Inc. Securities Fraud Lawsuit - marketscreener.com
Maravai Lifesciences Holdings Inc Azioni (MRVI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):